Design and Baseline Characteristics of Participants in the Clarifying the Optimal Application of Selective Laser Trabeculoplasty (SLT) Therapy (COAST) Trial 1
COAST is a timely and potentially highly impactful trial that will clarify the optimal utilization of SLT for long-term glaucoma management without the need for alternative therapies such as medications or surgery. The COAST sample closely resembles the population of newly-diagnosed POAG/OHT patients for whom primary SLT would be appropriate, optimizing generalizability of study results when available.
Authors
- Michael A. Kass (ORCID: https://orcid.org/0000-0003-0862-5956)
- Jenny Wolsk
- Tony Realini
- Stephen R. Wisniewski (ORCID: https://orcid.org/0000-0002-3877-9860)
- Tanya S. Kenkre (ORCID: https://orcid.org/0000-0003-3481-534X)
- G.K. Balasubramani
- Gus Gazzard
- the COAST Study Investigators
Institutions
- West Virginia University (US)
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- University of Pittsburgh (US)
- Washington University in St. Louis (US)
- West Virginia University Hospitals (US)
- University College London (GB)
Publication Details
- Journal
- Journal of Glaucoma
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1097/ijg.0000000000002717
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00